Vasculitis clinical trials at UCSF

1 research study open to eligible people

Vasculitis refers to inflammation in blood vessels. UCSF is looking into the impact of infliximab treatment for brain aneurysms that can cause strokes. This research could be important for patients with a specific type of aneurysm.

Showing trials for

  • Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

    open to eligible people ages 18 years and up

    Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

    San Francisco, California

Our lead scientists for Vasculitis research studies include .

Last updated: